Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Platelet Injections for Painful Degenerative Disc Disease
NCT05287867Recruiting
- Sponsor
- Regenexx
- Start
- May 2022
- Primary completion
- Dec 2026
- Modality
- Adipose-derived MSCs, Blood Coagulation Factors, Bone Marrow MSCs
- Countries
- 1
01
Overview
Randomised, single-blind trial of platelet-rich plasma, platelet lysate and platelet-poor plasma in degenerative disc disease (DDD) (2 arms), sponsored by Regenexx. Primary endpoints: Numeric Pain Scale and Modified Single Assessment Numerical Evaluation. Started May 2022; status: recruiting.
02
Drugs
platelet-rich plasmaplatelet lysateplatelet-poor plasma
03
Conditions
degenerative disc disease (DDD)
Beyond the preview
Go deeper on NCT05287867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05287867.